Back To: Home : Featured Technology : Functional Genomic Screening

CLICK HERE FOR WHAT'S NEW IN:
 

Industry leaders launch Actionable Genome Consortium
November 2014
by  |  Email the author
EDIT CONNECT

SHARING OPTIONS:

SAN DIEGO—Illumina Inc. and four leading cancer centers have established the Actionable Genome Consortium (AGC), an initiative that will recommend openly published standards for widespread use of next-generation sequencing to aid in treatment decision for cancer patients. Specifically, the AGC will aim to define the principles and content of the “cancer actionable genome,” a comprehensive description of genomic alterations that define individuals’ tumors. The founding members include, other than Illumina, the Dana-Farber Cancer Institute, Fred Hutchinson Cancer Research Center, MD Anderson Cancer Center and Memorial Sloan Kettering Cancer Center. The AGC will publish a list of actionable events—including best practices regarding biopsy samples, performance standards for sequencing, guidelines for clinical reports and standards for genetic variants—and include a research arm for collaborative, cross-institutional projects regarding leading challenges in molecular oncology.
 
Code:

Back


PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2018 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.